[Seite 129↓]

Literaturverzeichnis

Aarvak, T.; Chabaud, M.; Miossec, P. und Natvig, J. B. (1999): IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells, J Immunol 162) [3], Seite 1246-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9973376

Ali, M.; Ponchel, F.; Wilson, K. E.; Francis, M. J.; Wu, X.; Verhoef, A.; Boylston, A. W.; Veale, D. J.; Emery, P.; Markham, A. F.; Lamb, J. R. und Isaacs, J. D. (2001): Rheumatoid arthritis synovial T cells regulate transcription of several genes associated with antigen-induced anergy, J Clin Invest 107) [4], Seite 519-28. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11181651

Alonzi, T.; Fattori, E.; Lazzaro, D.; Costa, P.; Probert, L.; Kollias, G.; De Benedetti, F.; Poli, V. und Ciliberto, G. (1998): Interleukin 6 is required for the development of collagen-induced arthritis, J Exp Med 187) [4], Seite 461-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9463396

Amigorena, S.; Lankar, D.; Briken, V.; Gapin, L.; Viguier, M. und Bonnerot, C. (1998): Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens, J Exp Med 187) [4], Seite 505-15. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9463401

Andersson, E. C.; Hansen, B. E.; Jacobsen, H.; Madsen, L. S.; Andersen, C. B.; Engberg, J.; Rothbard, J. B.; McDevitt, G. S.; Malmstrom, V.; Holmdahl, R.; Svejgaard, A. und Fugger, L. (1998): Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice, Proc Natl Acad Sci U S A 95) [13], Seite 7574-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9636191

Andersson, M. und Holmdahl, R. (1990): Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse, Eur J Immunol 20) [5], Seite 1061-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1694131

Bathon, J. M.; Martin, R. W.; Fleischmann, R. M.; Tesser, J. R.; Schiff, M. H.; Keystone, E. C.; Genovese, M. C.; Wasko, M. C.; Moreland, L. W.; Weaver, A. L.; Markenson, J. und Finck, B. K. (2000): A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis, N Engl J Med 343) [22], Seite 1586-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11096165

Behlke, M. A.; Chou, H. S.; Huppi, K. und Loh, D. Y. (1986): Murine T-cell receptor mutants with deletions of beta-chain variable region genes, Proc Natl Acad Sci U S A 83) [3], Seite 767-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3456168

Beutler, B. und Cerami, A. (1989): The biology of cachectin/TNF--a primary mediator of the host response, Annu Rev Immunol 7), Seite 625-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2540776

Boissier, M. C.; Feng, X. Z.; Carlioz, A.; Roudier, R. und Fournier, C. (1987): Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis, Ann Rheum Dis 46) [9], Seite 691-700. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3675011

Brahn, E. und Trentham, D. E. (1984): Effect of antithymocyte serum on collagen arthritis in rats: evidence that T cells are involved in its pathogenesis, Cell Immunol 86) [2], Seite 421-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6610483

Brennan, F. M.; Chantry, D.; Jackson, A.; Maini, R. und Feldmann, M. (1989): Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis, Lancet 2) [8657], Seite 244-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2569055

Bresnihan, B.; Alvaro-Gracia, J. M.; Cobby, M.; Doherty, M.; Domljan, Z.; Emery, P.; Nuki, G.; Pavelka, K.; Rau, R.; Rozman, B.; Watt, I.; Williams, B.; Aitchison, R.; McCabe, D. und Musikic, P. (1998): Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist, Arthritis Rheum 41) [12], Seite 2196-204. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9870876

Brodeur, J. P.; Ruddy, S.; Schwartz, L. B. und Moxley, G. (1991): Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis, Arthritis Rheum 34) [12], Seite 1531-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1747138

Carlsen, S.; Hansson, A. S.; Olsson, H.; Heinegard, D. und Holmdahl, R. (1998): Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats, Clin Exp Immunol 114) [3], Seite 477-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9844060

Cathcart, E. S.; Hayes, K. C.; Gonnerman, W. A.; Lazzari, A. A. und Franzblau, C. (1986): Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen, Lab Invest 54) [1], Seite 26-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3941539

Cha, H. S.; Kim, T. J.; Kim, J. Y.; Lee, M. H.; Jeon, C. H.; Kim, J.; Bae, E. K.; Ahn, K. S. und Koh, E. M. (2004): Autoantibodies to glucose-6-phosphate isomerase are elevated in the synovial fluid of rheumatoid arthritis patients, Scand J Rheumatol 33) [3], Seite 179-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15228189

Chabaud, M.; Garnero, P.; Dayer, J. M.; Guerne, P. A.; Fossiez, F. und Miossec, P. (2000): Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis, Cytokine 12) [7], Seite 1092-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10880256

Chabaud, M.; Page, G. und Miossec, P. (2001): Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines, J Immunol 167) [10], Seite 6015-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11698482

Chang, Y. H.; Pearson, C. M. und Abe, C. (1980): Adjuvant polyarthritis. IV. Induction by a synthetic adjuvant: immunologic, histopathologic, and other studies, Arthritis Rheum 23) [1], Seite 62-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7352945

Chang, Y. H.; Pearson, C. M. und Chedid, L. (1981): Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan, J Exp Med 153) [4], Seite 1021-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6972989

Chaput, M.; Claes, V.; Portetelle, D.; Cludts, I.; Cravador, A.; Burny, A.; Gras, H. und Tartar, A. (1988): The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase, Nature 332) [6163], Seite 454-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3352744

Cobbold, S. P.; Martin, G. und Waldmann, H. (1990): The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies, Eur J Immunol 20) [12], Seite 2747-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1980112

Cohen, S.; Hurd, E.; Cush, J.; Schiff, M.; Weinblatt, M. E.; Moreland, L. W.; Kremer, J.; Bear, M. B.; Rich, W. J. und McCabe, D. (2002): Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial, Arthritis Rheum 46) [3], Seite 614-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11920396

Corr, M. und Crain, B. (2002): The role of FcgammaR signaling in the K/B x N serum transfer model of arthritis, J Immunol 169) [11], Seite 6604-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12444173

Corthay, A.; Johansson, A.; Vestberg, M. und Holmdahl, R. (1999): Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T cell-deficient (TCR mutant) mice, Int Immunol 11) [7], Seite 1065-73. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10383939

Courtenay, J. S.; Dallman, M. J.; Dayan, A. D.; Martin, A. und Mosedale, B. (1980): Immunisation against heterologous type II collagen induces arthritis in mice, Nature 283) [5748], Seite 666-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6153460

Cremer, M. A.; Ye, X. J.; Terato, K.; Griffiths, M. M.; Watson, W. C. und Kang, A. H. (1998): Immunity to type IX collagen in rodents: a study of type IX collagen for autoimmune and arthritogenic activities, Clin Exp Immunol 112) [3], Seite 375-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9649204

Despres, N.; Talbot, G.; Plouffe, B.; Boire, G. und Menard, H. A. (1995): Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera, J Clin Invest 95) [4], Seite 1891-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7706496

Dolhain, R. J.; van der Heiden, A. N.; ter Haar, N. T.; Breedveld, F. C. und Miltenburg, A. M. (1996): Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis, Arthritis Rheum 39) [12], Seite 1961-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8961900

Dorner, T.; Egerer, K.; Feist, E. und Burmester, G. R. (2004): Rheumatoid factor revisited, Curr Opin Rheumatol 16) [3], Seite 246-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15103252

Duncan, A. R. und Winter, G. (1988): The binding site for C1q on IgG, Nature 332) [6166], Seite 738-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3258649

Edwards, J. C. (1994): The nature and origins of synovium: experimental approaches to the study of synoviocyte differentiation, J Anat 184 ( Pt 3)), Seite 493-501. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7928638

Edwards, J. C.; Szczepanski, L.; Szechinski, J.; Filipowicz-Sosnowska, A.; Emery, P.; Close, D. R.; Stevens, R. M. und Shaw, T. (2004): Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis, N Engl J Med 350) [25], Seite 2572-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15201414

Elliott, M. J.; Maini, R. N.; Feldmann, M.; Kalden, J. R.; Antoni, C.; Smolen, J. S.; Leeb, B.; Breedveld, F. C.; Macfarlane, J. D.; Bijl, H. und et al. (1994): Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis, Lancet 344) [8930], Seite 1105-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7934491

Englert, M. E.; Ferguson, K. M.; Suarez, C. R.; Oronsky, A. L. und Kerwar, S. S. (1986): Passive transfer of collagen arthritis: heterogeneity of anti-collagen IgG, Cell Immunol 101) [2], Seite 373-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2428515

Erickson, R. P.; Tachibana, D. K.; Herzenberg, L. A. und Rosenberg, L. T. (1964): A Single Gene Controlling Hemolytic Complement and a Serum Antigen in the Mouse, J Immunol 92), Seite 611-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14139033

Faik, P.; Walker, J. I.; Redmill, A. A. und Morgan, M. J. (1988): Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3' sequences, Nature 332) [6163], Seite 455-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3352745

Fava, R.; Olsen, N.; Keski-Oja, J.; Moses, H. und Pincus, T. (1989): Active and latent forms of transforming growth factor beta activity in synovial effusions, J Exp Med 169) [1], Seite 291-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2909658

Feldmann, M.; Brennan, F. M. und Maini, R. N. (1996): Role of cytokines in rheumatoid arthritis, Annu Rev Immunol 14), Seite 397-440. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8717520

Firestein, G. S. (2003): Evolving concepts of rheumatoid arthritis, Nature 423) [6937], Seite 356-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12748655

Firestein, G. S.; Alvaro-Gracia, J. M. und Maki, R. (1990): Quantitative analysis of cytokine gene expression in rheumatoid arthritis, J Immunol 144) [9], Seite 3347-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2109776

Firestein, G. S. und Zvaifler, N. J. (1990): How important are T cells in chronic rheumatoid synovitis?, Arthritis Rheum 33) [6], Seite 768-73. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2194461

Frei, Y.; Lambris, J. D. und Stockinger, B. (1987): Generation of a monoclonal antibody to mouse C5 application in an ELISA assay for detection of anti-C5 antibodies, Mol Cell Probes 1) [2], Seite 141-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3453897

Fugger, L.; Rothbard, J. B. und Sonderstrup-McDevitt, G. (1996): Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen, Eur J Immunol 26) [4], Seite 928-33. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8625990

Gabriel, S. E. (2001): The epidemiology of rheumatoid arthritis, Rheum Dis Clin North Am 27) [2], Seite 269-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11396092

Glant, T. T.; Cs-Szabo, G.; Nagase, H.; Jacobs, J. J. und Mikecz, K. (1998): Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage, Arthritis Rheum 41) [6], Seite 1007-18. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9627010

Graham Solomons, J. T.; Zimmerly, E. M.; Burns, S.; Krishnamurthy, N.; Swan, M. K.; Krings, S.; Muirhead, H.; Chirgwin, J. und Davies, C. (2004): The crystal structure of mouse phosphoglucose isomerase at 1.6A resolution and its complex with glucose 6-phosphate reveals the catalytic mechanism of sugar ring opening, J Mol Biol 342) [3], Seite 847-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15342241

Gregersen, P. K.; Silver, J. und Winchester, R. J. (1987): The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis, Arthritis Rheum 30) [11], Seite 1205-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2446635

Gurney, M. E.; Apatoff, B. R.; Spear, G. T.; Baumel, M. J.; Antel, J. P.; Bania, M. B. und Reder, A. T. (1986): Neuroleukin: a lymphokine product of lectin-stimulated T cells, Science 234) [4776], Seite 574-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3020690

Gurney, M. E.; Heinrich, S. P.; Lee, M. R. und Yin, H. S. (1986): Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons, Science 234) [4776], Seite 566-74. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3764429

Hamano, Y.; Arase, H.; Saisho, H. und Saito, T. (2000): Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses, J Immunol 164) [12], Seite 6113-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10843660

Hassfeld, W.; Steiner, G.; Hartmuth, K.; Kolarz, G.; Scherak, O.; Graninger, W.; Thumb, N. und Smolen, J. S. (1989): Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis, Arthritis Rheum 32) [12], Seite 1515-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2597207

Hermann, E.; Fleischer, B.; Mayet, W. J.; Poralla, T. und Meyer zum Buschenfelde, K. H. (1989): Correlation of synovial fluid interleukin 6 (IL-6) activities with IgG concentrations in patients with inflammatory joint disease and osteoarthritis, Clin Exp Rheumatol 7) [4], Seite 411-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2591114

Herve, C. A.; Wait, R. und Venables, P. J. (2003): Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis, Rheumatology (Oxford) 42) [8], Seite 986-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12730513

Hietala, M. A.; Jonsson, I. M.; Tarkowski, A.; Kleinau, S. und Pekna, M. (2002): Complement deficiency ameliorates collagen-induced arthritis in mice, J Immunol 169) [1], Seite 454-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12077276

Holmdahl, R.; Bockermann, R.; Backlund, J. und Yamada, H. (2002): The molecular pathogenesis of collagen-induced arthritis in mice--a model for rheumatoid arthritis, Ageing Res Rev 1) [1], Seite 135-47. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12039453

Holmdahl, R.; Jansson, L.; Andersson, M. und Larsson, E. (1988): Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis, Immunology 65) [2], Seite 305-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3192274

Holmdahl, R.; Jansson, L.; Gullberg, D.; Rubin, K.; Forsberg, P. O. und Klareskog, L. (1985): Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II, Clin Exp Immunol 62) [3], Seite 639-46. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=4085150

Holmdahl, R.; Jansson, L.; Larsson, A. und Jonsson, R. (1990): Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies, Scand J Immunol 31) [2], Seite 147-57. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1968678

Holmdahl, R.; Jansson, L.; Larsson, E.; Rubin, K. und Klareskog, L. (1986): Homologous type II collagen induces chronic and progressive arthritis in mice, Arthritis Rheum 29) [1], Seite 106-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3947407

Holmdahl, R.; Klareskog, L.; Rubin, K.; Larsson, E. und Wigzell, H. (1985): T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones, Scand J Immunol 22) [3], Seite 295-306. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2413528

Hom, J. T.; Butler, L. D.; Riedl, P. E. und Bendele, A. M. (1988): The progression of the inflammation in established collagen-induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities, Eur J Immunol 18) [6], Seite 881-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3260183

Homann, D. und von Herrath, M. (2004): Regulatory T cells and type 1 diabetes, Clin Immunol 112) [3], Seite 202-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15308110

Ishikawa, H.; Smiley, J. D. und Ziff, M. (1975): Electron microscopic demonstration of immunoglobulin deposition in rheumatoid cartilage, Arthritis Rheum 18) [6], Seite 563-76. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=54168

Ito, A.; Itoh, Y.; Sasaguri, Y.; Morimatsu, M. und Mori, Y. (1992): Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts, Arthritis Rheum 35) [10], Seite 1197-201. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1418006

Ji, H.; Gauguier, D.; Ohmura, K.; Gonzalez, A.; Duchatelle, V.; Danoy, P.; Garchon, H. J.; Degott, C.; Lathrop, M.; Benoist, C. und Mathis, D. (2001): Genetic influences on the end-stage effector phase of arthritis, J Exp Med 194) [3], Seite 321-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11489951

Ji, H.; Ohmura, K.; Mahmood, U.; Lee, D. M.; Hofhuis, F. M.; Boackle, S. A.; Takahashi, K.; Holers, V. M.; Walport, M.; Gerard, C.; Ezekowitz, A.; Carroll, M. C.; Brenner, M.; Weissleder, R.; Verbeek, J. S.; Duchatelle, V.; Degott, C.; Benoist, C. und Mathis, D. (2002): Arthritis critically dependent on innate immune system players, Immunity 16) [2], Seite 157-68. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11869678

Ji, H.; Pettit, A.; Ohmura, K.; Ortiz-Lopez, A.; Duchatelle, V.; Degott, C.; Gravallese, E.; Mathis, D. und Benoist, C. (2002): Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis, J Exp Med 196) [1], Seite 77-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12093872

Jose, P. J.; Moss, I. K.; Maini, R. N. und Williams, T. J. (1990): Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase, Ann Rheum Dis 49) [10], Seite 747-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2241262

Jouen, F.; Vittecoq, O.; Leguillou, F.; Tabti-Titon, I.; Menard, J. F.; Mejjad, O.; Pouplin, S.; Boumier, P.; Fardellone, P.; Gayet, A.; Gilbert, D.; Tron, F. und Le Loet, X. (2004): Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis, Clin Exp Immunol 137) [3], Seite 606-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15320914

Kassahn, D.; Kolb, C.; Solomon, S.; Bochtler, P. und Illges, H. (2002): Few human autoimmune sera detect GPI, Nat Immunol 3) [5], Seite 411-2; author reply 412-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11976712

Katsikis, P. D.; Chu, C. Q.; Brennan, F. M.; Maini, R. N. und Feldmann, M. (1994): Immunoregulatory role of interleukin 10 in rheumatoid arthritis, J Exp Med 179) [5], Seite 1517-27. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8163935

Keffer, J.; Probert, L.; Cazlaris, H.; Georgopoulos, S.; Kaslaris, E.; Kioussis, D. und Kollias, G. (1991): Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis, Embo J 10) [13], Seite 4025-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1721867

Kjellen, P.; Brunsberg, U.; Broddefalk, J.; Hansen, B.; Vestberg, M.; Ivarsson, I.; Engstrom, A.; Svejgaard, A.; Kihlberg, J.; Fugger, L. und Holmdahl, R. (1998): The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules, Eur J Immunol 28) [2], Seite 755-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9521085

Klaus, G. G.; Pepys, M. B.; Kitajima, K. und Askonas, B. A. (1979): Activation of mouse complement by different classes of mouse antibody, Immunology 38) [4], Seite 687-95. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=521057

Kleinau, S.; Martinsson, P. und Heyman, B. (2000): Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors, J Exp Med 191) [9], Seite 1611-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10790435

Klippel, J. H. und Dieppe, P. A. (1998): Rheumatology, 2nd. Auflage, Mosby International, London.

Koch, A. E.; Burrows, J. C.; Haines, G. K.; Carlos, T. M.; Harlan, J. M. und Leibovich, S. J. (1991): Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues, Lab Invest 64) [3], Seite 313-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1706003

Kohashi, O.; Aihara, K.; Ozawa, A.; Kotani, S. und Azuma, I. (1982): New model of a synthetic adjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine- induced arthritis: clinical and histologic studies in athymic nude and euthymic rats, Lab Invest 47) [1], Seite 27-36. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7087395

Korganow, A. S.; Ji, H.; Mangialaio, S.; Duchatelle, V.; Pelanda, R.; Martin, T.; Degott, C.; Kikutani, H.; Rajewsky, K.; Pasquali, J. L.; Benoist, C. und Mathis, D. (1999): From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins, Immunity 10) [4], Seite 451-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10229188

Kotake, S.; Sato, K.; Kim, K. J.; Takahashi, N.; Udagawa, N.; Nakamura, I.; Yamaguchi, A.; Kishimoto, T.; Suda, T. und Kashiwazaki, S. (1996): Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation, J Bone Miner Res 11) [1], Seite 88-95. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8770701

Kouskoff, V.; Korganow, A. S.; Duchatelle, V.; Degott, C.; Benoist, C. und Mathis, D. (1996): Organ-specific disease provoked by systemic autoimmunity, Cell 87) [5], Seite 811-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8945509

Kremer, J. M.; Westhovens, R.; Leon, M.; Di Giorgio, E.; Alten, R.; Steinfeld, S.; Russell, A.; Dougados, M.; Emery, P.; Nuamah, I. F.; Williams, G. R.; Becker, J. C.; Hagerty, D. T. und Moreland, L. W. (2003): Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig, N Engl J Med 349) [20], Seite 1907-15. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14614165

Krenn, V.; Morawietz, L.; Haupl, T.; Neidel, J.; Petersen, I. und Konig, A. (2002): Grading of chronic synovitis--a histopathological grading system for molecular and diagnostic pathology, Pathol Res Pract 198) [5], Seite 317-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12092767

Kyburz, D.; Carson, D. A. und Corr, M. (2000): The role of CD40 ligand and tumor necrosis factor alpha signaling in the transgenic K/BxN mouse model of rheumatoid arthritis, Arthritis Rheum 43) [11], Seite 2571-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11083282

Lee, D. M.; Friend, D. S.; Gurish, M. F.; Benoist, C.; Mathis, D. und Brenner, M. B. (2002): Mast cells: a cellular link between autoantibodies and inflammatory arthritis, Science 297) [5587], Seite 1689-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12215644

Lee, Y. H.; Choi, S. J.; Ji, J. D. und Song, G. G. (2000): Serum creatine kinase in patients with rheumatic diseases, Clin Rheumatol 19) [4], Seite 296-300. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10941812

Lipsky, P. E.; van der Heijde, D. M.; St Clair, E. W.; Furst, D. E.; Breedveld, F. C.; Kalden, J. R.; Smolen, J. S.; Weisman, M.; Emery, P.; Feldmann, M.; Harriman, G. R. und Maini, R. N. (2000): Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group, N Engl J Med 343) [22], Seite 1594-602. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11096166

Maccioni, M.; Zeder-Lutz, G.; Huang, H.; Ebel, C.; Gerber, P.; Hergueux, J.; Marchal, P.; Duchatelle, V.; Degott, C.; van Regenmortel, M.; Benoist, C. und Mathis, D. (2002): Arthritogenic monoclonal antibodies from K/BxN mice, J Exp Med 195) [8], Seite 1071-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11956298

Maddison, P. J.; Isenberg, D; Woo, P; Glass, D. N. und Breedveld, F. C. (2004): Oxford Textbook of Rheumatology, 3rd ed.. Auflage, Oxford University Press, 0-19-850948-0.

Maini, R. N.; Breedveld, F. C.; Kalden, J. R.; Smolen, J. S.; Davis, D.; Macfarlane, J. D.; Antoni, C.; Leeb, B.; Elliott, M. J.; Woody, J. N.; Schaible, T. F. und Feldmann, M. (1998): Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis, Arthritis Rheum 41) [9], Seite 1552-63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9751087

Malmstrom, V.; Backlund, J.; Jansson, L.; Kihlberg, J. und Holmdahl, R. (2000): T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis, Arthritis Res 2) [4], Seite 315-26. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11056672

Malmstrom, V.; Michaelsson, E.; Burkhardt, H.; Mattsson, R.; Vuorio, E. und Holmdahl, R. (1996): Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis, Proc Natl Acad Sci U S A 93) [9], Seite 4480-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8633094

Mangialaio, S.; Ji, H.; Korganow, A. S.; Kouskoff, V.; Benoist, C. und Mathis, D. (1999): The arthritogenic T cell receptor and its ligand in a model of spontaneous arthritis, Arthritis Rheum 42) [12], Seite 2517-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10615996

Martin, B.; Banz, A.; Bienvenu, B.; Cordier, C.; Dautigny, N.; Becourt, C. und Lucas, B. (2004): Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo, J Immunol 172) [6], Seite 3391-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15004137

Matsumoto, I.; Lee, D. M.; Goldbach-Mansky, R.; Sumida, T.; Hitchon, C. A.; Schur, P. H.; Anderson, R. J.; Coblyn, J. S.; Weinblatt, M. E.; Brenner, M.; Duclos, B.; Pasquali, J. L.; El-Gabalawy, H.; Mathis, D. und Benoist, C. (2003): Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders, Arthritis Rheum 48) [4], Seite 944-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12687536

Matsumoto, I.; Maccioni, M.; Lee, D. M.; Maurice, M.; Simmons, B.; Brenner, M.; Mathis, D. und Benoist, C. (2002): How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease, Nat Immunol 3) [4], Seite 360-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11896391

Matsumoto, I.; Staub, A.; Benoist, C. und Mathis, D. (1999): Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme, Science 286) [5445], Seite 1732-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10576739

Maurice, M. M.; Nakamura, H.; van der Voort, E. A.; van Vliet, A. I.; Staal, F. J.; Tak, P. P.; Breedveld, F. C. und Verweij, C. L. (1997): Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis, J Immunol 158) [3], Seite 1458-65. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9013992

Michaelsson, E.; Andersson, M.; Engstrom, A. und Holmdahl, R. (1992): Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection, Eur J Immunol 22) [7], Seite 1819-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1378019

Moreland, L. W.; Alten, R.; Van den Bosch, F.; Appelboom, T.; Leon, M.; Emery, P.; Cohen, S.; Luggen, M.; Shergy, W.; Nuamah, I. und Becker, J. C. (2002): Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion, Arthritis Rheum 46) [6], Seite 1470-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12115176

Morgan, B. P.; Daniels, R. H. und Williams, B. D. (1988): Measurement of terminal complement complexes in rheumatoid arthritis, Clin Exp Immunol 73) [3], Seite 473-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3208454

Morgan, K.; Clague, R. B.; Shaw, M. J.; Firth, S. A.; Twose, T. M. und Holt, P. J. (1981): Native type II collagen--induced arthritis in the rat: the effect of complement depletion by cobra venom factor, Arthritis Rheum 24) [11], Seite 1356-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7317113

Morgan, M. E.; Sutmuller, R. P.; Witteveen, H. J.; van Duivenvoorde, L. M.; Zanelli, E.; Melief, C. J.; Snijders, A.; Offringa, R.; de Vries, R. R. und Toes, R. E. (2003): CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis, Arthritis Rheum 48) [5], Seite 1452-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12746920

Morita, Y.; Yamamura, M.; Kawashima, M.; Harada, S.; Tsuji, K.; Shibuya, K.; Maruyama, K. und Makino, H. (1998): Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis, Arthritis Rheum 41) [9], Seite 1669-76. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9751101

Muraki, Y.; Matsumoto, I.; Chino, Y.; Hayashi, T.; Suzuki, E.; Goto, D.; Ito, S.; Murata, H.; Tsutsumi, A. und Sumida, T. (2004): Glucose-6-phosphate isomerase variants play a key role in the generation of anti-GPI antibodies: possible mechanism of autoantibody production, Biochem Biophys Res Commun 323) [2], Seite 518-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15369782

Myers, L. K.; Brand, D. D.; Ye, X. J.; Cremer, M. A.; Rosloniec, E. F.; Bodo, M.; Myllyharju, J.; Helaakoski, T.; Nokelainen, M.; Pihlajaniemi, T.; Kivirikko, K.; Yang, C. L.; Ala-Kokko, L.; Prockop, D. J.; Notbohm, H.; Fietzek, P.; Stuart, J. M. und Kang, A. H. (1998): Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice, Immunology 95) [4], Seite 631-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9893056

Myers, L. K.; Miyahara, H.; Terato, K.; Seyer, J. M.; Stuart, J. M. und Kang, A. H. (1995): Collagen-induced arthritis in B10.RIII mice (H-2r): identification of an arthritogenic T-cell determinant, Immunology 84) [4], Seite 509-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7540590

Nakae, S.; Nambu, A.; Sudo, K. und Iwakura, Y. (2003): Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice, J Immunol 171) [11], Seite 6173-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14634133

Neumann, E.; Barnum, S. R.; Tarner, I. H.; Echols, J.; Fleck, M.; Judex, M.; Kullmann, F.; Mountz, J. D.; Scholmerich, J.; Gay, S. und Muller-Ladner, U. (2002): Local production of complement proteins in rheumatoid arthritis synovium, Arthritis Rheum 46) [4], Seite 934-45. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11953970

Nordling, C.; Karlsson-Parra, A.; Jansson, L.; Holmdahl, R. und Klareskog, L. (1992): Characterization of a spontaneously occurring arthritis in male DBA/1 mice, Arthritis Rheum 35) [6], Seite 717-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1318050

Ohshima, S.; Saeki, Y.; Mima, T.; Sasai, M.; Nishioka, K.; Nomura, S.; Kopf, M.; Katada, Y.; Tanaka, T.; Suemura, M. und Kishimoto, T. (1998): Interleukin 6 plays a key role in the development of antigen-induced arthritis, Proc Natl Acad Sci U S A 95) [14], Seite 8222-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9653168

Okamoto, H.; Yamamura, M.; Morita, Y.; Harada, S.; Makino, H. und Ota, Z. (1997): The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis, Arthritis Rheum 40) [6], Seite 1096-105. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9182920

Olsen, N. J. und Stein, C. M. (2004): New drugs for rheumatoid arthritis, N Engl J Med 350) [21], Seite 2167-79. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15152062

Pearson, C. M. (1956): Development of arthritis, periarthritis and periostitis in rats given adjuvants, Proc Soc Exp Biol Med 91) [1], Seite 95-101. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=13297719

Piguet, P. F.; Grau, G. E.; Vesin, C.; Loetscher, H.; Gentz, R. und Lesslauer, W. (1992): Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor, Immunology 77) [4], Seite 510-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1337334

Pincus, T.; Brooks, R. H. und Callahan, L. F. (1994): Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures, Ann Intern Med 120) [1], Seite 26-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8250453

Ranges, G. E.; Sriram, S. und Cooper, S. M. (1985): Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4, J Exp Med 162) [3], Seite 1105-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3928802

Reife, R. A.; Loutis, N.; Watson, W. C.; Hasty, K. A. und Stuart, J. M. (1991): SWR mice are resistant to collagen-induced arthritis but produce potentially arthritogenic antibodies, Arthritis Rheum 34) [6], Seite 776-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2053925

Roodman, G. D. (1992): Interleukin-6: an osteotropic factor?, J Bone Miner Res 7) [5], Seite 475-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1615755

Rosloniec, E. F.; Brand, D. D.; Myers, L. K.; Esaki, Y.; Whittington, K. B.; Zaller, D. M.; Woods, A.; Stuart, J. M. und Kang, A. H. (1998): Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen, J Immunol 160) [6], Seite 2573-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9510154

Rosloniec, E. F.; Brand, D. D.; Myers, L. K.; Whittington, K. B.; Gumanovskaya, M.; Zaller, D. M.; Woods, A.; Altmann, D. M.; Stuart, J. M. und Kang, A. H. (1997): An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen, J Exp Med 185) [6], Seite 1113-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9091584

Rosloniec, E. F.; Whittington, K. B.; Brand, D. D.; Myers, L. K. und Stuart, J. M. (1996): Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis, Cell Immunol 172) [1], Seite 21-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8806802

Sakaguchi, N.; Takahashi, T.; Hata, H.; Nomura, T.; Tagami, T.; Yamazaki, S.; Sakihama, T.; Matsutani, T.; Negishi, I.; Nakatsuru, S. und Sakaguchi, S. (2003): Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice, Nature 426) [6965], Seite 454-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14647385

Sakaguchi, S.; Sakaguchi, N.; Asano, M.; Itoh, M. und Toda, M. (1995): Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, J Immunol 155) [3], Seite 1151-64. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7636184

Sanmarti, R.; Collado, A.; Gratacos, J.; Herrera, B. E.; Font, J.; Canete, J. D.; Orellana, C. und Munoz-Gomez, J. (1996): Reduced serum creatine kinase activity in inflammatory rheumatic diseases, J Rheumatol 23) [2], Seite 310-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8882037

Sasai, M.; Saeki, Y.; Ohshima, S.; Nishioka, K.; Mima, T.; Tanaka, T.; Katada, Y.; Yoshizaki, K.; Suemura, M. und Kishimoto, T. (1999): Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice, Arthritis Rheum 42) [8], Seite 1635-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10446862

Schaller, M.; Burton, D. R. und Ditzel, H. J. (2001): Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease, Nat Immunol 2) [8], Seite 746-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11477412

Schepp, C. P.; Dannecker, L.; Haug, M.; Kummerle-Deschner, J.; Beck, H.; Kotter, I.; Holzer, U. und Dannecker, G. E. (2004): Autoantibodies in juvenile idiopathic arthritis: glucose-6-phosphate isomerase is not a specific target, J Rheumatol 31) [8], Seite 1630-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15290745

Schmitt, A.; Schubert, D.; Sengler, C. und Kamradt, T. (2004): Autoantibodies against glucose-6-phosphate isomerase are not a diagnostic marker for juvenile idiopathic arthritis, Ann Rheum Dis 63) [4], Seite 463. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15020348

Shaw, M. H.; Boyartchuk, V.; Wong, S.; Karaghiosoff, M.; Ragimbeau, J.; Pellegrini, S.; Muller, M.; Dietrich, W. F. und Yap, G. S. (2003): A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity, Proc Natl Acad Sci U S A 100) [20], Seite 11594-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14500783

Shimizu, K.; Tani, M.; Watanabe, H.; Nagamachi, Y.; Niinaka, Y.; Shiroishi, T.; Ohwada, S.; Raz, A. und Yokota, J. (1999): The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein, FEBS Lett 456) [2], Seite 295-300. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10456327

Shouda, T.; Yoshida, T.; Hanada, T.; Wakioka, T.; Oishi, M.; Miyoshi, K.; Komiya, S.; Kosai, K.; Hanakawa, Y.; Hashimoto, K.; Nagata, K. und Yoshimura, A. (2001): Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis, J Clin Invest 108) [12], Seite 1781-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11748261

Smolen, J. S. und Steiner, G. (1998): Are autoantibodies active players or epiphenomena?, Curr Opin Rheumatol 10) [3], Seite 201-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9608322

Smolen, J. S. und Steiner, G. (2003): Therapeutic strategies for rheumatoid arthritis, Nat Rev Drug Discov 2) [6], Seite 473-88. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12776222

Solomon, S. (2003): Role of pathogenic auto-antibodies and innate immunity mediators in K/BxN murine model for rheumatoid arthritis, Universität Konstanz.

Steiner, G.; Hartmuth, K.; Skriner, K.; Maurer-Fogy, I.; Sinski, A.; Thalmann, E.; Hassfeld, W.; Barta, A. und Smolen, J. S. (1992): Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex, J Clin Invest 90) [3], Seite 1061-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1522214

Steiner, G.; Tohidast-Akrad, M.; Witzmann, G.; Vesely, M.; Studnicka-Benke, A.; Gal, A.; Kunaver, M.; Zenz, P. und Smolen, J. S. (1999): Cytokine production by synovial T cells in rheumatoid arthritis, Rheumatology (Oxford) 38) [3], Seite 202-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10325658

Stuart, J. M.; Cremer, M. A.; Townes, A. S. und Kang, A. H. (1982): Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis, J Exp Med 155) [1], Seite 1-16. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7054355

Svendsen, P.; Andersen, C. B.; Willcox, N.; Coyle, A. J.; Holmdahl, R.; Kamradt, T. und Fugger, L. (2004): Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice, J Immunol 173) [11], Seite 7037-45. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15557201

Tada, Y.; Ho, A.; Koh, D. R. und Mak, T. W. (1996): Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis, J Immunol 156) [11], Seite 4520-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8666829

Tak, P. P.; Thurkow, E. W.; Daha, M. R.; Kluin, P. M.; Smeets, T. J.; Meinders, A. E. und Breedveld, F. C. (1995): Expression of adhesion molecules in early rheumatoid synovial tissue, Clin Immunol Immunopathol 77) [3], Seite 236-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7586733

Terato, K.; Hasty, K. A.; Reife, R. A.; Cremer, M. A.; Kang, A. H. und Stuart, J. M. (1992): Induction of arthritis with monoclonal antibodies to collagen, J Immunol 148) [7], Seite 2103-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1545120

Thorbecke, G. J.; Shah, R.; Leu, C. H.; Kuruvilla, A. P.; Hardison, A. M. und Palladino, M. A. (1992): Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice, Proc Natl Acad Sci U S A 89) [16], Seite 7375-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1502148

Trentham, D. E.; Dynesius, R. A. und David, J. R. (1978): Passive transfer by cells of type II collagen-induced arthritis in rats, J Clin Invest 62) [2], Seite 359-66. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=27533

Trentham, D. E.; Townes, A. S. und Kang, A. H. (1977): Autoimmunity to type II collagen an experimental model of arthritis, J Exp Med 146) [3], Seite 857-68. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=894190

Tsutsumi, S.; Gupta, S. K.; Hogan, V.; Collard, J. G. und Raz, A. (2002): Activation of small GTPase Rho is required for autocrine motility factor signaling, Cancer Res 62) [15], Seite 4484-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12154059

van Boekel, M. A.; Vossenaar, E. R.; van den Hoogen, F. H. und van Venrooij, W. J. (2002): Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value, Arthritis Res 4) [2], Seite 87-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11879544

Van Damme, J.; Opdenakker, G.; Simpson, R. J.; Rubira, M. R.; Cayphas, S.; Vink, A.; Billiau, A. und Van Snick, J. (1987): Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor, J Exp Med 165) [3], Seite 914-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3493322

van den Berg, W. B.; van de Putte, L. B.; Zwarts, W. A. und Joosten, L. A. (1984): Electrical charge of the antigen determines intraarticular antigen handling and chronicity of arthritis in mice, J Clin Invest 74) [5], Seite 1850-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6501574

van der Lubbe, P. A.; Dijkmans, B. A.; Markusse, H. M.; Nassander, U. und Breedveld, F. C. (1995): A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis, Arthritis Rheum 38) [8], Seite 1097-106. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7639806

van Gaalen, F. A.; Toes, R. E.; Ditzel, H. J.; Schaller, M.; Breedveld, F. C.; Verweij, C. L. und Huizinga, T. W. (2004): Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis, Arthritis Rheum 50) [2], Seite 395-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14872481

Vassalli, P. (1992): The pathophysiology of tumor necrosis factors, Annu Rev Immunol 10), Seite 411-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1590993

Verheijden, G. F.; Rijnders, A. W.; Bos, E.; Coenen-de Roo, C. J.; van Staveren, C. J.; Miltenburg, A. M.; Meijerink, J. H.; Elewaut, D.; de Keyser, F.; Veys, E. und Boots, A. M. (1997): Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis, Arthritis Rheum 40) [6], Seite 1115-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9182922

Verwilghen, J.; Vertessen, S.; Stevens, E. A.; Dequeker, J. und Ceuppens, J. L. (1990): Depressed T-cell reactivity to recall antigens in rheumatoid arthritis, J Clin Immunol 10) [2], Seite 90-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1970986

Wahl, S. M. (1994): Transforming growth factor beta: the good, the bad, and the ugly, J Exp Med 180) [5], Seite 1587-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7964446

Wang, Y.; Kristan, J.; Hao, L.; Lenkoski, C. S.; Shen, Y. und Matis, L. A. (2000): A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis, J Immunol 164) [8], Seite 4340-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10754334

Wang, Y.; Rollins, S. A.; Madri, J. A. und Matis, L. A. (1995): Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease, Proc Natl Acad Sci U S A 92) [19], Seite 8955-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7568051

Ward, P. A. und Zvaifler, N. J. (1971): Complement-derived leukotactic factors in inflammatory synovial fluids of humans, J Clin Invest 50) [3], Seite 606-16. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=5545123

Watanabe, H.; Carmi, P.; Hogan, V.; Raz, T.; Silletti, S.; Nabi, I. R. und Raz, A. (1991): Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor, J Biol Chem 266) [20], Seite 13442-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1649192

Watanabe, H.; Takehana, K.; Date, M.; Shinozaki, T. und Raz, A. (1996): Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide, Cancer Res 56) [13], Seite 2960-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8674049

Watson, W. C.; Brown, P. S.; Pitcock, J. A. und Townes, A. S. (1987): Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis, Arthritis Rheum 30) [4], Seite 460-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3580014

Watson, W. C. und Townes, A. S. (1985): Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci, J Exp Med 162) [6], Seite 1878-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3934318

Weyand, C. M.; Hicok, K. C.; Conn, D. L. und Goronzy, J. J. (1992): The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis, Ann Intern Med 117) [10], Seite 801-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1416553

Williams, R. O.; Feldmann, M. und Maini, R. N. (1992): Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis, Proc Natl Acad Sci U S A 89) [20], Seite 9784-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1409699

Williams, R. O. und Whyte, A. (1996): Anti-CD4 monoclonal antibodies suppress murine collagen-induced arthritis only at the time of primary immunisation, Cell Immunol 170) [2], Seite 291-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8660829

Wipke, B. T. und Allen, P. M. (2001): Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis, J Immunol 167) [3], Seite 1601-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11466382

Wipke, B. T.; Wang, Z.; Kim, J.; McCarthy, T. J. und Allen, P. M. (2002): Dynamic visualization of a joint-specific autoimmune response through positron emission tomography, Nat Immunol 3) [4], Seite 366-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11896393

Wolfe, F. und Hawley, D. J. (1998): The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients, J Rheumatol 25) [11], Seite 2108-17. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9818651

Wooley, P. H.; Dutcher, J.; Widmer, M. B. und Gillis, S. (1993): Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice, J Immunol 151) [11], Seite 6602-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8245488

Wooley, P. H.; Luthra, H. S.; Stuart, J. M. und David, C. S. (1981): Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates, J Exp Med 154) [3], Seite 688-700. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6792316

Wooley, P. H.; Seibold, J. R.; Whalen, J. D. und Chapdelaine, J. M. (1989): Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease, Arthritis Rheum 32) [8], Seite 1022-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2765002

Xu, W.; Seiter, K.; Feldman, E.; Ahmed, T. und Chiao, J. W. (1996): The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase, Blood 87) [11], Seite 4502-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8639816

Yuasa, T.; Kubo, S.; Yoshino, T.; Ujike, A.; Matsumura, K.; Ono, M.; Ravetch, J. V. und Takai, T. (1999): Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis, J Exp Med 189) [1], Seite 187-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9874575

Ziolkowska, M.; Koc, A.; Luszczykiewicz, G.; Ksiezopolska-Pietrzak, K.; Klimczak, E.; Chwalinska-Sadowska, H. und Maslinski, W. (2000): High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism, J Immunol 164) [5], Seite 2832-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10679127


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
24.06.2005